Best Biotech Stocks Right Now
AbbVie (NYSE:ABBV)AbbVie is a drug company with a strong exposure to immunology and oncology. The company’s top drug, Humira, represents close to half of the company’s current profits. The company was spun off from Abbott in early 2013.
- ▪AbbVie (NYSE:ABBV)AbbVie is a drug company with a strong exposure to immunology and oncology.
- ▪The company’s top drug, Humira, represents close to half of the company’s current profits.
- ▪The company was spun off from Abbott in early 2013.
2 outlets in our directory ran this story, first to last over 18 hours. All of the coverage we found sits in one bucket: centre. That one-sidedness is itself worth noticing.
- ▪ This REIT Is Today’s Best S&P 500 Stock — Yahoo Finance
Benzinga files mainly under news. We currently carry 10 of its stories.
Opening excerpt (first ~120 words) tap to expand
AbbVie (NYSE:ABBV)AbbVie is a drug company with a strong exposure to immunology and oncology. The company’s top drug, Humira, represents close to half of the company’s current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women’s health. AbbVie(NYSE:ABBV)$259.362.44[0.95%]Quote.Price.last-update: 7:49 PM (Delayed 15-Minutes)Get Real Time HereOpen258.540Close259.360Vol / Avg.4.195M / 6.994MMkt Cap456.429BDay Range256.765 - 260.22052 Wk Range186.770 - 261.635Trade with PublicSellCompare BrokersStart Your Free 14-Day Benzinga Pro TrialImmix Biopharma (NASDAQ:IMMX)Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Benzinga.
